Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murugabaskar Balan

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Plos Pathogens|June 16, 2016
Correction: Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus InfectionsJian-Da Lin, Ningguo Feng, Adrish Sen, et al.
Acta Diabetologica|February 23, 2017
Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumorsCristian Loretelli, Robert F Moore, Moufida Ben Nasr, et al.
Cancer Letters|August 19, 2025
Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stressAkash Sabarwal, Marc Machaalani, Laxminarayan Rawat, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Plos Pathogens|June 16, 2016
Correction: Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus InfectionsJian-Da Lin, Ningguo Feng, Adrish Sen, et al.
Acta Diabetologica|February 23, 2017
Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumorsCristian Loretelli, Robert F Moore, Moufida Ben Nasr, et al.
Cancer Letters|August 19, 2025
Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stressAkash Sabarwal, Marc Machaalani, Laxminarayan Rawat, et al.
Pageof 3